BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11589933)

  • 1. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I; Stern RS
    Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
    van de Kerkhof PC; de Rooij MJ
    Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS; Nichols KT; Väkevä LH
    N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
    Nijsten TE; Stern RS
    J Invest Dermatol; 2003 Aug; 121(2):252-8. PubMed ID: 12880415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of melanoma in association with long-term exposure to PUVA.
    Stern RS;
    J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS; Laird N
    Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.
    Paul CF; Ho VC; McGeown C; Christophers E; Schmidtmann B; Guillaume JC; Lamarque V; Dubertret L
    J Invest Dermatol; 2003 Feb; 120(2):211-6. PubMed ID: 12542524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use.
    Behnam SM; Behnam SE; Koo JY
    J Drugs Dermatol; 2005; 4(2):189-94. PubMed ID: 15776776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA; Marcil I; Stern RS
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
    Henseler T; Christophers E; Hönigsmann H; Wolff K
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):108-16. PubMed ID: 3805379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients.
    Zumtobel U; Schwarze HP; Favre M; Taïeb A; Delaunay M
    Dermatology; 2001; 202(2):127-30. PubMed ID: 11306834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS
    Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin carcinomas and treatment with photochemotherapy (PUVA).
    Lindskov R
    Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for psoriasis and the risk of malignancy.
    Patel RV; Clark LN; Lebwohl M; Weinberg JM
    J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous malignancies during treatment with efalizumab and infliximab: When temporal relationship does not mean causality.
    Di Lernia V; Ricci C
    J Dermatolog Treat; 2011 Aug; 22(4):229-32. PubMed ID: 20666674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.